Found: 4
Select item for more details and to access through your institution.
Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 3, p. 192, doi. 10.1016/j.clpt.2004.04.011
- By:
- Publication type:
- Article
CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 3, p. 213, doi. 10.1016/j.clpt.2003.10.004
- By:
- Publication type:
- Article
Effect of levothyroxine administration on intestinal P-glycoprotein expression: Consequences for drug disposition<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 72, n. 3, p. 256, doi. 10.1067/mcp.2002.126706
- By:
- Publication type:
- Article
Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 61, n. 4, p. 440, doi. 10.1111/j.1365-2125.2006.02599.x
- By:
- Publication type:
- Article